Revenue
2012
2013
2014
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | $24,581 | $15,479 | $59,257 |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | −$30,115 | −$80,943 | $27,036 |
| Research & development | $1.2M | $50,000 | — | $54,275 | $158,000 | $30,000 | $441,320 | $630,518 | $867,052 | $967,348 | $766,726 | $218,000 | — | — |
| Operating expenses | $3.7M | $894,305 | $960,692 | $942,874 | $1.1M | $1.4M | $2.4M | $2.9M | $9.1M | $2.0M | $4.6M | $2.5M | $736,532 | — |
| Operating income | −$3.7M | −$894,305 | −$960,692 | −$942,874 | −$1.1M | −$1.4M | −$2.4M | −$2.9M | −$9.1M | −$2.0M | −$4.6M | −$2.5M | −$817,475 | −$1.5M |
| EBITDAderived | — | — | — | — | — | — | — | — | — | −$2.0M | −$4.6M | −$2.5M | −$699,018 | −$1.4M |
| Net income | −$2.0M | −$1.5M | −$1.6M | −$1.5M | −$1.7M | −$2.5M | −$3.7M | −$3.2M | −$9.1M | −$2.0M | −$4.0M | −$4.4M | −$975,056 | −$892,114 |
| Basic EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.01 | -$0.02 | -$0.03 | -$0.01 | -$0.02 |
| Diluted EPSper diluted share | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.03 | -$0.01 | — | -$0.01 | -$0.01 | -$0.02 |